Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation

Kamar N, Marion O, Rostaing L, Cointault O, Ribes D, Lavayssière L, et al.. Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation. Am J Transplant. 2016;16(5):1474-1479.

Publication Type:

Journal Article

Authors:

Kamar, N.; Marion, O.; Rostaing, L.; Cointault, O.; Ribes, D.; Lavayssière, L.; Esposito, L.; Del Bello, A.; Metivier, S.; Barange, K.; Izopet, J.; Alric, L.

Source:

Am J Transplant, Volume 16, Issue 5, p.1474-1479 (2016)

Keywords:

clinical research / practice, infection and infectious agents, infectious disease, kidney disease: infectious, kidney transplantation / nephrology, viral: hepatitis C

Cited On:

External Third-party Web Link:

https://www.ncbi.nlm.nih.gov/pubmed/26587971

Export Citation:
RIS Format
Top